Skip to content

Bard® Nasogastric Sump Tube with Enfit™ EN0042120Recalls & reported problems

C. R. Bard, Inc. · Bard® Nasogastric Sump Tube with Enfit™ · Class 2

All models of Bard Nasogastric Sump Tube with Enfit (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00801741113789), received between May 31, 2023 and Feb 14, 2024 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Defective Component” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Dec 20, 2023Class IIOpen, Classified

    BD (C.R. Bard) has received user complaints reporting that during use of BD Bard NG Sump Tubes with ENFit Connectors, inadequate or reduced suction, decompression, and drainage occurred.

    Z-0791-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Defective Component1
  • Suction Failure1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 14, 2024Defective Component; Defective Component

    IT WAS REPORTED THAT THE NASOGASTRIC TUBE HAD UNKNOWN ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18701935 ↗
  • MalfunctionMay 31, 2023Suction Failure; Suction Failure

    IT WAS REPORTED THAT THE CUSTOMER WAS HAVING ISSUES WITH THE NEW ENFIT NASOGASTRIC TUBES WHEN USED FOR SUCTION. STATED THAT IT SEEMS THAT WHEN THE DRAINAGE WAS THICK OR CONTAINS FOOD PARTICLES THE SUCTION DID NOT WORK BECAUSE THE ENFIT OPENING WAS CONSIDERABLY SMALLER THAN THE LEGACY NASOGASTRIC TUBE OPENING. THEIR OPERATING ROOM (OR) STAFF FELT THAT THEY WERE NOT ABLE TO QUICKLY DECOMPRESS THE STOMACH WITH THE ENFIT NASOGASTRIC TUBES AND THEY HAVE REACHED OUT TO THEIR AHS PARTNERS, AND THEY ALSO SEEM TO HAVE THE SAME ISSUE. AS PER FOLLOW-UP VIA EMAIL ON 23MAY2023, IT WAS REPORTED THAT THE CUSTOMER WAS HAVING ISSUES WITH THE NEW ENFIT NASOGASTRIC TUBES EN0042180 (12FR, 14FR, 16FR) WHEN USED FOR SUCTION. IT SEEMS THAT WHEN THE DRAINAGE WAS THICK OR CONTAINS FOOD PARTICLES THE SUCTION DID NOT WORK BECAUSE THE ENFIT OPENING WAS CONSIDERABLY SMALLER THAN THE LEGACY NASOGASTRIC TUBE OPENING. THEIR OPERATING ROOM (OR) STAFF FELT THAT THEY WERE NOT ABLE TO QUICKLY DECOMPRESS THE STOMACH WITH THE ENFIT NASOGASTRIC TUBES.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17029934 ↗

Other TUBE, NASOGASTRIC devices

All TUBE, NASOGASTRIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page